Cargando…

Effect of diabetic kidney disease on therapeutic strategies for coronary artery disease: ten year follow-up

Background: The best treatment for coronary artery disease (CAD) in patients with type 2 diabetes (DM2) and chronic kidney disease is unknown. Methods: This retrospective study included MASS registry patients with DM2 and multivessel CAD, stratified by kidney function. Primary endpoint was combined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batista, Daniel Valente, Hueb, Whady, Lima, Eduardo Gomes, Rezende, Paulo Cury, Garzillo, Cibele Larrosa, Garcia, Rosa Maria Rahmi, Filho, Jaime Paula Pessoa Linhares, Martins, Eduardo Bello, Junior, Carlos Vicente Serrano, Ramires, Jose Antonio Franchini, Filho, Roberto Kalil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436946/ https://www.ncbi.nlm.nih.gov/pubmed/34433133 http://dx.doi.org/10.18632/aging.203476

Ejemplares similares

Association Between Stress Testing–Induced Myocardial Ischemia and Clinical Events in Patients With Multivessel Coronary Artery Disease
por: Garzillo, Cibele Larrosa, et al.
Publicado: (2019)

Surgical and percutaneous revascularization outcomes based on SYNTAX I, II, and residual scores: a long-term follow-up study
por: Martins, Eduardo Bello, et al.
Publicado: (2021)

Myocardial injury in diabetic patients with multivessel coronary artery disease after revascularization interventions
por: Rezende, Paulo Cury, et al.
Publicado: (2017)

Effect of Hypoglycemic Agents on Ischemic Preconditioning in Patients With Type 2 Diabetes and Symptomatic Coronary Artery Disease
por: Rahmi, Rosa Maria, et al.
Publicado: (2013)

Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease
por: Rezende, Paulo Cury, et al.
Publicado: (2020)

Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients
por: Rezende, Paulo Cury, et al.
Publicado: (2015)

Significant association of SYNTAX score on release of cardiac biomarkers in uncomplicated post-revascularization procedures among patients with stable multivessel disease: MASS-V Study group
por: de Azevedo, Diogo Freitas Cardoso, et al.
Publicado: (2020)

Long-term analysis of ventricular function in patients with symptomatic coronary disease who underwent on-pump or off-pump coronary artery bypass grafting
por: Silva, Rafael Rocha Mol, et al.
Publicado: (2022)

Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF)
por: Rezende, Paulo Cury, et al.
Publicado: (2020)

On-pump versus off-pump coronary artery bypass surgery in patients older than 60 years: five-year follow-up of MASS III trial
por: Vieira de Melo, Rodrigo Morel, et al.
Publicado: (2014)

Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance
por: Oikawa, Fernando Teiichi Costa, et al.
Publicado: (2017)

Significant elevation of biomarkers of myocardial necrosis after coronary artery bypass grafting without myocardial infarction established assessed by cardiac magnetic resonance
por: da Costa, Leandro Menezes Alves, et al.
Publicado: (2017)

Hypotheses, rationale, design, and methods for evaluation of ischemic preconditioning assessed by sequential exercise tests in diabetic and non-diabetic patients with stable coronary artery disease – a prospective study
por: Rezende, Paulo Cury, et al.
Publicado: (2013)

The Influence of Diabetes Mellitus in Myocardial Ischemic Preconditioning
por: Rezende, Paulo Cury, et al.
Publicado: (2016)

Chronic troponin elevation assessed by myocardial T1 mapping in patients with stable coronary artery disease
por: Segre, Carlos Alexandre W., et al.
Publicado: (2023)

Acompanhamento de Dois Anos de Pacientes com Cardiopatia Isquêmica Crônica em um Centro Especializado no Brasil
por: Moreira, Eduardo Martelli, et al.
Publicado: (2023)

Troponin in diabetic patients with and without chronic coronary artery disease
por: Segre, Carlos Alexandre Wainrober, et al.
Publicado: (2015)

Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus
por: Sprandel, Marilia C O, et al.
Publicado: (2015)

Coronavirus disease-2019 and heart: assessment of troponin and cardiovascular comorbidities as prognostic markers in patients hospitalized with coronavirus disease-2019 in a tertiary center in Brazil
por: Pinesi, Henrique Trombini, et al.
Publicado: (2023)

Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study
por: Scudeler, Thiago Luis, et al.
Publicado: (2022)

Myocardial microstructure assessed by T1 mapping after on-pump and off-pump coronary artery bypass grafting
por: Dallazen, Anderson Roberto, et al.
Publicado: (2023)

COVID-19 AND HEART: ASSESSMENT OF TROPONIN AND CARDIOVASCULAR COMORBIDITIES AS PROGNOSTIC MARKERS IN PATIENTS HOSPITALIZED FOR COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Pinesi, Henrique, et al.
Publicado: (2022)

Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial
por: Hueb, Whady, et al.
Publicado: (2012)

Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial
por: Hueb, Whady, et al.
Publicado: (2010)

Effect of chronic kidney disease in ischemic cardiomyopathy: Long-term follow-up - REVISION-DM2 trial
por: Hueb, Thiago Ovanessian, et al.
Publicado: (2019)

Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease
por: Costa, Leandro M.A., et al.
Publicado: (2015)

Single Photon Computed Tomography-Myocardial Perfusion Scintigraphy. Diagnostic Tool Anticipating the Disease
por: Hueb, Whady
Publicado: (2019)

A case of mid-apical obstructive hypertrophic cardiomyopathy treated with a transapical myectomy approach: a case report
por: Scudeler, Thiago Luis, et al.
Publicado: (2014)

Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial
por: Hueb, Thiago, et al.
Publicado: (2018)

RELATIONSHIP BETWEEN ADMISSION TROPONIN AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH HEART DISEASE AND COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Moreira, Eduardo, et al.
Publicado: (2022)

CORONARY ARTERY BYPASS GRAFT SURGERY OUTCOMES IN PATIENTS WITH AND WITHOUTCOVID-19 DURING THE PANDEMIC FIRST WAVE
por: Matuck, Bruna Scarpa, et al.
Publicado: (2023)

Better Technology, More Spending, Worse Outcomes
por: Hueb, Whady
Publicado: (2018)

Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21
por: Gioli-Pereira, Luciana, et al.
Publicado: (2012)

Genetic Variants of Diabetes Risk and Incident Cardiovascular Events in Chronic Coronary Artery Disease
por: Sousa, André Gustavo P., et al.
Publicado: (2011)

Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial
por: Brandão, Sara Michelly Gonçalves, et al.
Publicado: (2018)

Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery
por: Borges, Jorge Chiquie, et al.
Publicado: (2010)

Efficacy of aneurysmectomy in patients with severe left ventricular dysfunction: favorable short‐ and long‐term results in ischemic cardiomyopathy
por: Serrano, Carlos Vicente, et al.
Publicado: (2010)

Association between UCP2 A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial disease
por: Gioli-Pereira, Luciana, et al.
Publicado: (2013)

Behavior of Ultrasensitive C-Reactive Protein in Myocardial Revascularization with and without Cardiopulmonary Bypass
por: Abrantes, Rafael Diniz, et al.
Publicado: (2018)

A randomized comparative study of patients undergoing myocardial revascularization with or without cardiopulmonary bypass surgery: The MASS III Trial
por: Hueb, Whady, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_mglcm8i9756jh15apbv9m3ca78